Why Illumina Rallied 36.6% in December
Shares of gene sequencing leader (NASDAQ: ILMN) rallied 36.6% in December, according to data from S&P Global Market Intelligence.
Investors might not be quite so excited, as Illumina entered the month more than 80% below its all-time highs from 2021.
But hopes for a bottoming and recovery surfaced in December, as Illumina received several positive analyst notes, and activist investor Carl Icahn made his next move in shaking up the company's board of directors.
Source Fool.com
Illumina Inc. Aktie
Die Illumina Inc. Aktie steht gut da: Deutlich mehr Buy- als Sell-Einschätzungen in der Community.
Das Kursziel von 160 € für Illumina Inc. impliziert eine deutliche Steigerung um über 20% gegenüber 112.16 €.